The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer-Reference-Cited by-同舟云学术

The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non–small cell lung cancer

Published:2023-09 Issue:3 Volume:166 Page:637-654
ISSN:0022-5223
Container-title:The Journal of Thoracic and Cardiovascular Surgery
language:en
Short-container-title:The Journal of Thoracic and Cardiovascular Surgery

Author:

Kidane Biniam,Bott Matthew,Spicer Jonathan,Backhus Leah,Chaft Jamie,Chudgar Neel,Colson Yolonda,D'Amico Thomas A.,David Elizabeth,Lee Jay,Najmeh Sara,Sepesi Boris,Shu Catherine,Yang Jeffrey,Swanson Scott,Stiles Brendon

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Pulmonary and Respiratory Medicine,Surgery

Reference147 articles.

1. Timing of local and distant failure in resected lung cancer: implications for reported rates of local failure;Boyd;J Thorac Oncol,2010

2. Analysis of first recurrence and survival in patients with stage I non–small cell lung cancer treated with surgical resection or stereotactic radiation therapy;Crabtree;J Thorac Cardiovasc Surg,2014

3. Differences in patterns of recurrence in early-stage versus locally advanced non–small cell lung cancer;Lou;Ann Thorac Surg,2014

4. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for Lung Cancer;Goldstraw;J Thorac Oncol,2016

5. Induction chemoradiation is not superior to induction chemotherapy alone in stage IIIA lung cancer;Shah;Ann Thorac Surg,2012

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neoadjuvant vs Adjuvant Chemoimmunotherapy for Stage II-IIIB Non-Small Cell Lung Cancer;The Annals of Thoracic Surgery;2024-09

2. Pneumonectomy for non–small cell lung cancer. A National Cancer Database analysis of geographic and temporal trends, outcomes, and associated factors;Surgery;2024-09

3. MDT-BRIDGE: Neoadjuvant Durvalumab Plus Chemotherapy Followed by Either Surgery and Adjuvant Durvalumab or Chemoradiotherapy and Consolidation Durvalumab in Resectable or Borderline-resectable Stage IIB–IIIB NSCLC;Clinical Lung Cancer;2024-09

4. New perspectives on inoperable early-stage lung cancer management: Clinicians, physicists, and biologists unveil strategies and insights;The Journal of Liquid Biopsy;2024-09

5. Induction therapy for non–small cell lung cancer;The Journal of Thoracic and Cardiovascular Surgery;2024-08